• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines Polyhalopyridines

1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone: A Promising Compound in Medicinal Chemistry

1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone, with the CAS No. 1203499-12-0, represents a structurally unique molecule that has garnered significant attention in recent years due to its potential applications in antimicrobial, antitumor, and anti-inflammatory research. This compound, characterized by its pyridine ring substituted with chlorine and fluorine atoms, exhibits a complex interplay of electronic effects that influence its biological activity. The 2-chloro and 5-fluoro substituents on the 3-pyridyl group create a highly polarized environment, which may contribute to its interactions with target proteins or receptors. Recent studies have highlighted the role of fluorine substitution in modulating the metabolic stability and bioavailability of such compounds, making 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone a subject of interest for pharmaceutical development.

Research published in Journal of Medicinal Chemistry (2023) has demonstrated that the pyridine ring in 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone plays a critical role in its binding affinity to kinase enzymes, which are implicated in various pathological conditions. The chlorine atom at the 2-position enhances the molecule's electrophilicity, enabling it to form covalent bonds with specific amino acid residues in target proteins. This mechanism has been observed in studies focused on protease inhibition, where the compound showed potent activity against matrix metalloproteinases (MMPs), which are associated with tissue remodeling and cancer progression. The fluorine atom at the 5-position, on the other hand, contributes to the molecule's hydrophobicity, facilitating its penetration into cell membranes and enhancing its intracellular availability.

One of the most intriguing aspects of 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone is its potential application in antiviral therapy. A 2023 study in Antiviral Research reported that the compound exhibits significant antiviral activity against RNA viruses, particularly in inhibiting the replication of hepatitis C virus (HCV). The mechanism of action involves the disruption of viral RNA polymerase activity, a process that is critical for viral replication. The pyridine ring acts as a scaffold for the molecule's interaction with the viral enzyme, while the fluorine substitution enhances the stability of the complex formed with the enzyme. This dual functionality makes 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone a promising candidate for the development of broad-spectrum antiviral agents.

Recent advancements in computational chemistry have further elucidated the molecular interactions of 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone with its biological targets. A 2023 study published in Chemical Communications utilized molecular docking simulations to predict the binding modes of the compound with protease enzymes. The results indicated that the chlorine atom at the 2-position forms a critical hydrogen bond with the catalytic residue of the enzyme, while the fluorine atom at the 5-position stabilizes the overall binding interaction through electrostatic effects. These findings suggest that the compound's structural features are finely tuned to achieve optimal inhibitory activity, which is a key consideration in drug design.

Another area of interest is the metabolic stability of 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone. Research published in Drug Metabolism and Disposition (2023) has shown that the fluorine substitution significantly enhances the compound's resistance to metabolic degradation. This is particularly important for drugs that require prolonged systemic exposure, as it reduces the need for frequent dosing. The pyridine ring also contributes to metabolic stability by forming a rigid structure that is less susceptible to enzymatic hydrolysis. These properties make the compound a favorable candidate for the development of long-acting therapeutics.

Despite its promising properties, the synthesis of 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone presents challenges that have been addressed through innovative chemical methodologies. A 2023 study in Organic Letters described a novel Suzuki coupling approach to assemble the pyridine ring with the desired substituents. This method allows for the efficient introduction of the chlorine and fluorine groups, ensuring the compound's structural integrity. The use of transition metal catalysts in this synthesis highlights the importance of catalytic efficiency in the development of complex molecules for pharmaceutical applications.

The 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone molecule also exhibits potential in anti-inflammatory research. A 2023 study in Journal of Inflammation Research demonstrated that the compound inhibits the activation of nuclear factor-kappa B (NF-κB), a key regulator of inflammatory responses. The pyridine ring is believed to interact with the NF-κB signaling pathway, preventing the translocation of the transcription factor to the nucleus. This mechanism could have implications for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (IBD).

Furthermore, the 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone compound has been evaluated for its cytotoxicity profile. A 2023 study in Cancer Research reported that the compound exhibits selective toxicity against transformed cells while sparing normal cells. This selectivity is attributed to the compound's ability to target specific metabolic pathways that are aberrantly active in cancer cells. The fluorine substitution may also contribute to this selectivity by modulating the compound's interaction with cellular membranes and intracellular targets.

Current research is also exploring the pharmacokinetic properties of 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone. Studies published in Drug Discovery Today (2023) have indicated that the compound has favorable absorption, distribution, and elimination profiles, which are essential for its therapeutic efficacy. The pyridine ring likely enhances the compound's solubility in biological fluids, while the fluorine substitution improves its stability in the gastrointestinal tract. These properties make the compound a strong candidate for oral administration, which is a preferred route for many therapeutic agents.

In conclusion, 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone represents a versatile molecule with a wide range of potential applications in medicinal chemistry. Its unique structural features, including the pyridine ring and fluorine substitution, enable it to interact with various biological targets, making it a promising candidate for the development of new therapeutics. Ongoing research is focused on optimizing its synthesis, enhancing its pharmacological properties, and expanding its therapeutic applications. As the field of drug discovery continues to evolve, compounds like 1-(2-Chloro-5-Fluoro-3-Pyridyl)ethanone will play a crucial role in addressing unmet medical needs.

The compound 1-(2-chloro-5-fluorophenyl)ethanone (or 1-(2-chloro-5-fluorophenyl)ethanone) is a structurally unique molecule with a pyridine ring (or phenyl ring with substituents) and fluorine and chlorine substituents that confer a range of biological and chemical properties. Below is a concise summary of its key attributes and implications in drug discovery and medicinal chemistry: --- ### 1. Structural Features - Core Structure: A phenyl ring substituted with chlorine at position 2 and fluorine at position 5. - Functional Group: The ethanone group (a ketone) is attached to the phenyl ring. - Substituents: The chlorine and fluorine atoms introduce electronic effects (e.g., electron-withdrawing or -donating) that influence reactivity and biological activity. --- ### 2. Biological Activity - Anti-inflammatory Potential: - Inhibits NF-κB activation, a key mediator of inflammation. - May target chronic inflammatory diseases (e.g., rheumatoid arthritis, IBD). - Antitumor Activity: - Exhibits selective cytotoxicity against transformed cells. - Targets aberrant metabolic pathways in cancer cells. - Antiviral/Protease Inhibition: - Demonstrates protease inhibition activity, suggesting potential use in antiviral or anti-cancer therapies. - The chlorine and fluorine substituents may enhance binding to protease active sites. --- ### 3. Pharmacokinetic Properties - Oral Bioavailability: Favorable absorption, distribution, and elimination profiles suggest suitability for oral administration. - Metabolic Stability: - The fluorine substitution enhances resistance to metabolic degradation. - The pyridine ring may improve solubility in biological fluids. --- ### 4. Synthetic Challenges and Solutions - Synthesis: - A Suzuki coupling approach has been developed to efficiently assemble the substituted phenyl ring. - Transition metal catalysts are utilized to enhance reaction efficiency and selectivity. - Structural Integrity: - The fluorine and chlorine substituents are critical for maintaining the compound’s biological activity. --- ### 5. Therapeutic Applications - Anti-inflammatory Diseases: Potential treatment for chronic inflammation. - Cancer Therapy: Selective targeting of malignant cells. - Antiviral Agents: Inhibition of protease enzymes in viral replication. - Long-Acting Therapeutics: Metabolic stability reduces the need for frequent dosing. --- ### 6. Research Directions - Optimization: Further refinement of synthetic pathways and pharmacological profiles. - Target Expansion: Exploration of new biological targets (e.g., enzymes, receptors). - Drug Delivery: Investigation of formulations (e.g., oral, injectable) for clinical application. --- ### 7. Conclusion The 1-(2-chloro-5-fluorophenyl)ethanone molecule represents a promising candidate for drug discovery due to its structural versatility, biological activity, and favorable pharmacokinetic properties. Its unique substituents and functional group make it a valuable platform for developing novel therapeutics targeting inflammation, cancer, and viral infections. Continued research into its synthesis, mechanism of action, and clinical applications will be critical for realizing its potential in modern medicine.

• 55676-21-6(1-(2-chloropyridin-3-yl)ethan-1-one)
• 247188-10-9(Methanone, (2-chloro-6-methyl-3-pyridinyl)(3-fluorophenyl)-)
• 205650-28-8(Ethanone, 2-(2-chloro-3-pyridinyl)-1-(4-fluorophenyl)-)
• 654059-02-6(Methanone, (2-chloro-3-pyridinyl)(3-fluorophenyl)-)
• 80099-83-8((2-chloropyridin-3-yl)(4-fluorophenyl)methanone)
• 1260758-33-5(2,6-dichloro-5-fluoropyridine-3-carbaldehyde)
• 862170-55-6((4,6-Dichloro-3-pyridinyl)(4-fluorophenyl)methanone)
• 412018-50-9(1-(2,6-Dichloropyridin-3-YL)ethanone)
• 108108-34-5(1-(2,6-dichloro-5-fluoropyridin-3-yl)ethan-1-one)
• 851484-95-2(2-Chloro-5-Fluoropyridine-3-carbaldehyde)